Enterprise Value

22.8M

Cash

205.4M

Avg Qtr Burn

-56.08M

Short % of Float

14.85%

Insider Ownership

1.63%

Institutional Own.

-

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Tab-cel (tabelecleucel) Details
Viral infection, Epstein-Barr virus, Nasopharyngeal carcinoma, Solid organ transplant, Hematopoietic cell transplantation

BLA

Submission

ATA188 Details
Multiple sclerosis, Epstein-Barr virus

Big Mover™

Susp. Mover™

Phase 2

Data readout